Exogenous Engraftment: Host-specificity in Probiotic Administration

Tyler   J.   Long
doi:10.2174/0126666499268615231127065836
Keywords: Microbiome, Host-specificity, Phylosymbiosis, Probiotics, Microbial Engraftment, Host-Microbe
[1]
Parfrey LW, Moreau CS, Russell JA. Introduction: The host‐associated microbiome: Pattern, process and function. Mol Ecol  2018; 27(8): 1749-65.
 [http://dx.doi.org/10.1111/mec.14706] [PMID: 29727917]

[2]
NIH Office of Dietary Supplements. 2022. Available from: https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/

[3]
Gibbons SM. Defining microbiome health through a host lens. mSystems  2019; 4(3): e00155-19.
 [http://dx.doi.org/10.1128/mSystems.00155-19] [PMID: 31120028]

[4]
Long TJ. Home-field advantage: Why host-specificity is important for therapeutic microbial engraftment. Microbiol Biotechnol Lett  2023; 51: 124-7.
 [http://dx.doi.org/10.48022/mbl.2212.12002]

[5]
Walter J. Murine gut microbiota-diet trumps genes. Cell Host Microbe  2015; 17(1): 3-5.
 [http://dx.doi.org/10.1016/j.chom.2014.12.004] [PMID: 25590753]

[6]
Walter J, Maldonado-Gómez MX, Martínez I. To engraft or not to engraft: An ecological framework for gut microbiome modulation with live microbes. Curr Opin Biotechnol  2018; 49: 129-39.
 [http://dx.doi.org/10.1016/j.copbio.2017.08.008] [PMID: 28866242]

[7]
Szajewska H, Guarino A, Hojsak I, et al. Use of probiotics for management of acute gastroenteritis: A position paper by the ESPGHAN working group for probiotics and prebiotics. J pediatr gastroenterol nutr  2014; 58(4): 531-9.
 [http://dx.doi.org/10.1097/MPG.0000000000000320] [PMID: 24614141]

[8]
Kang DW, Adams JB, Gregory AC, et al. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome  2017; 5(1): 10.
 [http://dx.doi.org/10.1186/s40168-016-0225-7] [PMID: 28122648]

[9]
Li SS, Zhu A, Benes V, et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science  2016; 352(6285): 586-9.
 [http://dx.doi.org/10.1126/science.aad8852] [PMID: 27126044]

[10]
Chung H, Pamp SJ, Hill JA, et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell  2012; 149(7): 1578-93.
 [http://dx.doi.org/10.1016/j.cell.2012.04.037] [PMID: 22726443]

[11]
Mallott EK, Amato KR. Host specificity of the gut microbiome. Nat Rev Microbiol  2021; 19(10): 639-53.
 [http://dx.doi.org/10.1038/s41579-021-00562-3] [PMID: 34045709]

[12]
Brucker RM, Bordenstein SR. The hologenomic basis of speciation: Gut bacteria cause hybrid lethality in the genus Nasonia. Science  2013; 341(6146): 667-9.
 [http://dx.doi.org/10.1126/science.1240659] [PMID: 23868918]

[13]
Bron PA, van Baarlen P, Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol  2012; 10(1): 66-78.
 [http://dx.doi.org/10.1038/nrmicro2690] [PMID: 22101918]

[14]
Li H, Limenitakis JP, Fuhrer T, et al. The outer mucus layer hosts a distinct intestinal microbial niche. Nat Commun  2015; 6(1): 8292.
 [http://dx.doi.org/10.1038/ncomms9292] [PMID: 26392213]

[15]
Smillie CS, Sauk J, Gevers D, et al. Strain-tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell Host Microbe  2018; 23(2): 229-240.e5.
 [http://dx.doi.org/10.1016/j.chom.2018.01.003] [PMID: 29447696]

[16]
Chang CY, Bajić D, Vila JCC, Estrela S, Sanchez A. Emergent coexistence in multispecies microbial communities. Science  2023; 381(6655): 343-8.
 [http://dx.doi.org/10.1126/science.adg0727] [PMID: 37471535]

[17]
Ianiro G, Punčochář M, Karcher N, et al. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nat Med  2022; 28(9): 1913-23.
 [http://dx.doi.org/10.1038/s41591-022-01964-3] [PMID: 36109637]

[18]
Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: A systematic review of randomized controlled trials. Genome Med  2016; 8(1): 52.
 [http://dx.doi.org/10.1186/s13073-016-0300-5] [PMID: 27159972]

[19]
Maldonado-Gómez MX, Martínez I, Bottacini F, et al. Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host Microbe  2016; 20(4): 515-26.
 [http://dx.doi.org/10.1016/j.chom.2016.09.001] [PMID: 27693307]

[20]
Uyeno Y, Shigemori S, Shimosato T. Effect of probiotics/prebiotics on cattle health and productivity. Microbes Environ  2015; 30(2): 126-32.
 [http://dx.doi.org/10.1264/jsme2.ME14176] [PMID: 26004794]

[21]
Ramesh D, Vinothkanna A, Rai AK, Vignesh VS. Isolation of potential probiotic Bacillus spp. and assessment of their subcellular components to induce immune responses in Labeo rohita against Aeromonas hydrophila. Fish Shellfish Immunol  2015; 45(2): 268-76.
 [http://dx.doi.org/10.1016/j.fsi.2015.04.018] [PMID: 25917974]

[22]
Costello EK, Stagaman K, Dethlefsen L, Bohannan BJM, Relman DA. The application of ecological theory toward an understanding of the human microbiome. Science  2012; 336(6086): 1255-62.
 [http://dx.doi.org/10.1126/science.1224203] [PMID: 22674335]

[23]
Seedorf H, Griffin NW, Ridaura VK, et al. Bacteria from diverse habitats colonize and compete in the mouse gut. Cell  2014; 159(2): 253-66.
 [http://dx.doi.org/10.1016/j.cell.2014.09.008] [PMID: 25284151]

[24]
Faith JJ, Guruge JL, Charbonneau M, et al. The long-term stability of the human gut microbiota. Science  2013; 341(6141): 1237439.
 [http://dx.doi.org/10.1126/science.1237439] [PMID: 23828941]

[25]
Biavati B, Mattarelli P. Bifidobacterium. in Bergey’s Manual of Systematic Bacteriology In: The Actinobacteria. Springer Science & Business Media.   2012; 5: pp. 171-206.

[26]
Walter J. Ecological role of lactobacilli in the gastrointestinal tract: Implications for fundamental and biomedical research. Appl Environ Microbiol  2008; 74(16): 4985-96.
 [http://dx.doi.org/10.1128/AEM.00753-08] [PMID: 18539818]

[27]
Sornplang P, Piyadeatsoontorn S. Probiotic isolates from unconventional sources: A review. J Anim Sci Technol  2016; 58(1): 26.
 [http://dx.doi.org/10.1186/s40781-016-0108-2] [PMID: 27437119]

[28]
Cummins J, Ho M-W. Genetically modified probiotics should be banned. Microb Ecol Health Dis  2005; 17: 66-8.

[29]
US Food and Drug Administration. Draft guidance for industry: Policy regarding quantitative labeling of dietary supplements containing live microbials. 2018. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/draft-guidance-industry-policy-regarding-quantitative-labeling-dietary-supplements-containing-live

[30]
Venugopalan V, Shriner KA, Wong-Beringer A. Regulatory oversight and safety of probiotic use. Emerg Infect Dis  2010; 16(11): 1661-5.
 [http://dx.doi.org/10.3201/eid1611.100574] [PMID: 21029521]

[31]
US Food and Drug Administration. Drugs Development & Approval Process. FDA. 2023. Available from: https://www.fda.gov/drugs/development-approval-process-drugs

[32]
Olle B. Medicines from microbiota. Nat Biotechnol  2013; 31(4): 309-15.
 [http://dx.doi.org/10.1038/nbt.2548] [PMID: 23563425]

[33]
PEDICINI. European Parliament. Parliamentary Question E-004201/2017: Use of the term ‘probiotic’ and nutrition claims. 2017. Available from: https://www.europarl.europa.eu/doceo/document/E-8-2017-004201_EN.html

[34]
Wright A. Regulating the safety of probiotics-the European approach. Curr Pharm Des  2005; 11(1): 17-23.
 [http://dx.doi.org/10.2174/1381612053382322] [PMID: 15638749]

[35]
Turck D, Bohn T, Castenmiller J, et al. Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283. EFSA J  2021; 19(9): e06780.
 [PMID: 34484452]

[36]
European Food Safety Authority. Guidance on the characterisation of microorganisms used as feed additives or as production organisms 2018. Available from: https://www.efsa.europa.eu/en/efsajournal/pub/5206

[37]
Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC - Commission Declaration. OJ L  2001; 106.

[38]
Charbonneau MR, Isabella VM, Li N, Kurtz CB. Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nat Commun  2020; 11(1): 1738.
 [http://dx.doi.org/10.1038/s41467-020-15508-1] [PMID: 32269218]

[39]
Shen TCD, Chehoud C, Ni J, et al. Dietary regulation of the gut microbiota engineered by a minimal defined bacterial consortium. PLoS One  2016; 11(5): e0155620.
 [http://dx.doi.org/10.1371/journal.pone.0155620] [PMID: 27176607]

[40]
Shen H, Zhao Z, Zhao Z, Chen Y, Zhang L. Native and engineered probiotics: Promising agents against related systemic and intestinal diseases. Int J Mol Sci  2022; 23(2): 594.
 [http://dx.doi.org/10.3390/ijms23020594] [PMID: 35054790]

[41]
Russell BJ, Brown SD, Siguenza N, et al. Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes. Cell  2022; 185(17): 3263-3277.e15.
 [http://dx.doi.org/10.1016/j.cell.2022.06.050] [PMID: 35931082]

[42]
Slomski A. Postantibiotic microbiome therapeutic reduces C difficile recurrence. JAMA  2022; 327(12): 1118.
 [http://dx.doi.org/10.1001/jama.2022.3753] [PMID: 35315889]

[43]
Xia JY, Hepler C, Tran P, Waldeck NJ, Bass J, Prindle A. Engineered calprotectin-sensing probiotics for IBD surveillance in humans. Proc Natl Acad Sci USA  2023; 120(32): e2221121120.
 [http://dx.doi.org/10.1073/pnas.2221121120] [PMID: 37523538]

[44]
van de Wijgert JHHM, Verwijs MC, Gill AC, Borgdorff H, van der Veer C, Mayaud P. Pathobionts in the vaginal microbiota: Individual participant data meta-analysis of three sequencing studies. Front Cell Infect Microbiol  2020; 10: 129.
 [http://dx.doi.org/10.3389/fcimb.2020.00129] [PMID: 32351902]

[45]
Ma J, Lyu Y, Liu X, et al. Engineered probiotics. Microb Cell Fact  2022; 21(1): 72.
 [http://dx.doi.org/10.1186/s12934-022-01799-0] [PMID: 35477497]

[46]
Mazhar SF, Afzal M, Almatroudi A, et al. The prospects for the therapeutic implications of genetically engineered probiotics. J Food Qual  2020; 2020: 1-11.
 [http://dx.doi.org/10.1155/2020/9676452]

[47]
Aggarwal N, Breedon AME, Davis CM, Hwang IY, Chang MW. Engineering probiotics for therapeutic applications: Recent examples and translational outlook. Curr Opin Biotechnol  2020; 65: 171-9.
 [http://dx.doi.org/10.1016/j.copbio.2020.02.016] [PMID: 32304955]

[48]
Rottinghaus AG, Amrofell MB, Moon TS. Biosensing in smart engineered probiotics. Biotechnol J  2020; 15(10): 1900319.
 [http://dx.doi.org/10.1002/biot.201900319] [PMID: 31860168]

[49]
Zhou Y, Han Y. Engineered bacteria as drug delivery vehicles: Principles and prospects. Engineering Microbiology  2022; 2(3): 100034.
 [http://dx.doi.org/10.1016/j.engmic.2022.100034]
Rights & Permissions Print Cite
Article Metrics
8
1
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/0126666499268615231127065836	Print ISSN 2666-6499
Publisher Name Bentham Science Publisher	Online ISSN 2666-6502
Current Probiotics

Exogenous Engraftment: Host-specificity in Probiotic Administration

Related Journals

Related Books
